XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid‑in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balances (in shares) at Dec. 31, 2020 85,299,885        
Beginning Balances at Dec. 31, 2020 $ 81,658        
Redeemable Convertible Preferred Stock          
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares) 53,522,099        
Issuance of redeemable convertible preferred stock, net of issuance costs $ 115,831        
Ending Balances (in shares) at Mar. 31, 2021 138,821,984        
Ending Balances at Mar. 31, 2021 $ 197,489        
Beginning Balances (in shares) at Dec. 31, 2020   1,244,139      
Beginning Balances at Dec. 31, 2020 (41,490) $ 0 $ 1,021 $ 0 $ (42,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   16,453      
Issuance of common stock upon exercise of stock options 29   29    
Vesting of restricted common stock (in shares)   4,326      
Vesting of early exercised options (in shares)   6,529      
Vesting of early exercised options 8   8    
Stock‑based compensation 164   164    
Net loss (8,380)       (8,380)
Ending Balances (in shares) at Mar. 31, 2021   1,271,447      
Ending Balances at Mar. 31, 2021 $ (49,669) $ 0 1,222 0 (50,891)
Beginning Balances (in shares) at Dec. 31, 2020 85,299,885        
Beginning Balances at Dec. 31, 2020 $ 81,658        
Ending Balances (in shares) at Jun. 30, 2021 138,821,984        
Ending Balances at Jun. 30, 2021 $ 197,489        
Beginning Balances (in shares) at Dec. 31, 2020   1,244,139      
Beginning Balances at Dec. 31, 2020 (41,490) $ 0 1,021 0 (42,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive loss 0        
Net loss (18,281)        
Ending Balances (in shares) at Jun. 30, 2021   1,405,725      
Ending Balances at Jun. 30, 2021 $ (59,014) $ 0 1,778 0 (60,792)
Beginning Balances (in shares) at Mar. 31, 2021 138,821,984        
Beginning Balances at Mar. 31, 2021 $ 197,489        
Ending Balances (in shares) at Jun. 30, 2021 138,821,984        
Ending Balances at Jun. 30, 2021 $ 197,489        
Beginning Balances (in shares) at Mar. 31, 2021   1,271,447      
Beginning Balances at Mar. 31, 2021 (49,669) $ 0 1,222 0 (50,891)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   119,359      
Issuance of common stock upon exercise of stock options 212   212   0
Vesting of restricted common stock (in shares)   4,327      
Vesting of early exercised options (in shares)   10,592      
Vesting of early exercised options 18   18    
Stock‑based compensation 326   326    
Other comprehensive loss 0        
Net loss (9,901)       (9,901)
Ending Balances (in shares) at Jun. 30, 2021   1,405,725      
Ending Balances at Jun. 30, 2021 $ (59,014) $ 0 1,778 0 (60,792)
Beginning Balances (in shares) at Dec. 31, 2021 0        
Beginning Balances at Dec. 31, 2021 $ 0        
Ending Balances (in shares) at Mar. 31, 2022 0        
Ending Balances at Mar. 31, 2022 $ 0        
Beginning Balances (in shares) at Dec. 31, 2021 31,224,336 31,224,336      
Beginning Balances at Dec. 31, 2021 $ 298,718 $ 3 392,384 0 (93,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   24,891      
Issuance of common stock upon exercise of stock options 50   50    
Vesting of early exercised options (in shares)   15,224      
Vesting of early exercised options 35   35    
Stock‑based compensation 1,794   1,794    
Other comprehensive loss (1,535)     (1,535)  
Net loss (21,671)       (21,671)
Ending Balances (in shares) at Mar. 31, 2022   31,264,451      
Ending Balances at Mar. 31, 2022 $ 277,391 $ 3 394,263 (1,535) (115,340)
Beginning Balances (in shares) at Dec. 31, 2021 0        
Beginning Balances at Dec. 31, 2021 $ 0        
Ending Balances (in shares) at Jun. 30, 2022 0        
Ending Balances at Jun. 30, 2022 $ 0        
Beginning Balances (in shares) at Dec. 31, 2021 31,224,336 31,224,336      
Beginning Balances at Dec. 31, 2021 $ 298,718 $ 3 392,384 0 (93,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 30,150        
Other comprehensive loss $ (2,265)        
Net loss $ (44,850)        
Ending Balances (in shares) at Jun. 30, 2022 31,284,448 31,284,448      
Ending Balances at Jun. 30, 2022 $ 256,039 $ 3 396,820 (2,265) (138,519)
Beginning Balances (in shares) at Mar. 31, 2022 0        
Beginning Balances at Mar. 31, 2022 $ 0        
Ending Balances (in shares) at Jun. 30, 2022 0        
Ending Balances at Jun. 30, 2022 $ 0        
Beginning Balances (in shares) at Mar. 31, 2022   31,264,451      
Beginning Balances at Mar. 31, 2022 277,391 $ 3 394,263 (1,535) (115,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   5,259      
Issuance of common stock upon exercise of stock options 11   11    
Vesting of early exercised options (in shares)   14,738      
Vesting of early exercised options 34   34    
Stock‑based compensation 2,512   2,512    
Other comprehensive loss (730)     (730)  
Net loss $ (23,179)       (23,179)
Ending Balances (in shares) at Jun. 30, 2022 31,284,448 31,284,448      
Ending Balances at Jun. 30, 2022 $ 256,039 $ 3 $ 396,820 $ (2,265) $ (138,519)